GPR155 and Huntington disease: Originally, Gpr155 (G-protein-coupled receptor 155) was identified in Huntington’s disease patients, where it was reported to be downregulated in the caudate nucleus, suggesting involvement in pathophysiological mechanisms affecting specific brain structures [1].